From Name:
From Email:
To Name:
To Email:

Optional Message:


FDA reviewer recommends against Pfizer drug

from The Wall Street Journal

A Food and Drug Administration medical reviewer recommended the agency not approve a drug developed by a Pfizer subsidiary to treat a rare genetic disorder that affects the nervous system because there's "inadequate" evidence the drug works. Pfizer subsidiary FoldRx is seeking FDA approval of a drug called tafamidis to treat an inherited condition called transthyretin familial amyloid polyneuropathy. more


Powered by MultiBriefs
7701 Las Colinas Blvd., Ste. 800, Irving, TX 75063